BJA Advance Access originally published online on April 19, 2008
British Journal of Anaesthesia 2008 101(1):121-124; doi:10.1093/bja/aen087
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Analgesia from a veterinary perspective
Comparative Biology Centre, The Medical School, University of Newcastle, Newcastle-upon-Tyne NE2 4HH, UK
* E-mail: p.a.flecknell{at}ncl.ac.uk
| Abstract |
|---|
|
|
|---|
The last decade has seen continued progress in both the recognition and management of animal pain. This upsurge in the use of analgesics in animals is welcome, but the main areas of use continue to be the control of postoperative or post-trauma pain, and the management of musculoskeletal pain, in companion animals and horses. The management of pain associated with other conditions, such as soft-tissue inflammation or cancer, is still relatively neglected. Pain management in farm animals, and in animals used in biomedical research could also be improved further. Apart from providing some interesting parallels with pain management in people, development of veterinary pain management has potentially much greater significance. For many years, animal pain management has benefited from the use of analgesics used in man. In the future, it may be that a better understanding of animal pain, and in particular chronic pain states, may lead to translation of therapies in the opposite direction.
Keywords: anaesthesia, veterinary; pain
| Introduction |
|---|
|
|
|---|
The development of pain management in animals has many parallels with the development of pain management in human infants, with the treatment of pain being a relatively rare event historically. In some situations doubts were expressed as to whether animals experienced pain to any significant extent, and discussions of analgesic use were dominated by concerns related to the possibility of undesirable side-effects. During the last two to three decades there has been a gradual evolution of new veterinary attitudes to animal pain. The use of analgesics has become more widespread,3 5 19 27 but is still relatively low overall. This increased use of analgesics has been accompanied by improvements in our ability to assess pain in animals, and by the introduction of a range of analgesic compounds marketed specifically for veterinary use. Although this upsurge in the use of analgesics in animals is welcome, the main areas of use continue to be the control of postoperative or post-trauma pain, and the management of musculoskeletal pain, in companion animals and horses. The management of pain associated with other conditions, such as soft-tissue inflammation or cancer, is still relatively neglected. Use of analgesics for animals used in biomedical research is relatively low overall,28 with some marked variation between the species. Pain management in farm animals is also relatively low.14
| Factors influencing analgesic use |
|---|
|
|
|---|
A range of concerns continue to restrict the use of analgesics in animals. Their relative importance varies depending upon the type of animal—for example analgesics may not be used in laboratory species because the analgesic used might interfere with the goals of a particular research project. In farm animal practice, economic considerations may be a significant factor.14 Analgesic may be withheld from wild or exotic species owing to the uncertainty of their appropriate dose rates, and also dosing regimens might limit their use. In all groups however, a major factor influencing the use of analgesics remains our relatively poor ability to assess pain in animals.
It is generally accepted that all vertebrates possess the necessary sensory mechanisms to detect and process noxious stimuli; hence, it is reasonable to assume that a procedure that would cause pain in man would evoke a similar experience in animals. The behaviours expressed by many species however, will differ greatly from those observed in people, and in some circumstances may be masked completely by the animals' response to being observed. This lack of easily identifiable responses to pain can lead to the assumption that significant pain cannot be present. This obstacle to effective pain management can only be overcome by the development of robust pain scoring systems. It is not sufficient to simply give the animal the benefit of the doubt and administer an analgesic, as without a method of pain assessment it is neither possible to determine whether the dose given was effective, nor is it possible to determine when therapy should be repeated or discontinued. Until recently, pain assessment in animals was based primarily on clinical opinion—often with no reliable validation of the measures used. Initial attempts to develop pain scoring tools were limited by poor study design; the assessment criteria used were frequently highly subjective, the studies did not include placebo control groups, and little consideration was given to the effects of anaesthesia and analgesic administration on the behaviour and clinical appearance of otherwise normal animals. Appropriate controls are particularly important. Many pain scoring schemes rely on assesing changes in normal behaviour, and this can be markedly altered by anaesthetic and analgesic agents, introducing major confounding effects.29 Including untreated control groups when studying post-surgical or post-procedure pain raises significant ethical concerns to those undertaking pain assessment studies. Many studies in companion and farm animals are carried out in veterinary schools in which students are taught that animals experience pain, and that analgesics should therefore be administered. Deliberately withholding analgesics in circumstances thought likely to result in pain may therefore be considered unacceptable. This problem is addressed in studies of pain in human subjects by implementing an intervention analgesia protocol. If the subject is assessed as experiencing pain above a certain level, they are removed from the study and given an analgesic. This assessment can be carried out by someone not directly involved in the study, and the approach has been used successfully in a number of veterinary clinical studies.9 18
Despite these problems, more recent studies have resulted in the development of reasonably well-validated pain scales for the assessment of some types of post-surgical pain in dogs,15 cats,31 and laboratory rodents.30 36 Pain assessment methods have also been developed to determine the relative degrees of pain caused by a number of routine farming practices, such as dehorning of cattle and castration and tail-docking of lambs.21 24 Application of these behaviour-based pain measurement tools has enabled comparisons of the efficacy of different types of analgesics, determination of their dose rates, and the appropriate durations of analgesic therapy. Further development of practical assessment schemes for routine clinical use should enable adjustment of analgesic regimens to meet the needs of individual animals.
Pain assessment methods have also been developed for the evaluation of musculoskeletal pain, such as that caused by arthritis in dogs. Both clinical scoring of lameness and more objective measures using force-plate analysis have been applied to assess the relative efficacy of different analgesic treatments.11 33
Clinically applicable pain scoring methods that can be used in animals with other potentially painful conditions have not been developed. As a consequence, although cancer pain is recognized in animals,2 our ability to manage it is very limited. Analgesics are also relatively underused to control pain associated with a range of other inflammatory conditions such as otitis and ocular disease.
Although considerable progress has been made in the development of pain scoring systems, problems still remain. The scoring schemes currently available for clinical use require 10–30 min to undertake effectively. Allocating this period of time to assess an animal may not seem significant, but to allow effective pain management, assessments may need repeating at least hourly. In a busy veterinary clinic, with limited resources, this can be difficult. When dealing with laboratory animals, it is common for 20 or more animals to undergo surgery over a 2–3 h period, putting even greater pressure on resources. Similar problems can be encountered when dealing with farm animals. This problem may be overcome as the importance of pain management becomes more widely appreciated. As in man, post-surgical pain in animals has a series of undesirable consequences, including an increased surgical stress response, impairment of normal gastro-intestinal and urinary function, inhibition of normal activity and behaviours, such as eating, drinking, and grooming. When dealing with companion animals, these consequences of unalleviated pain can slow down recovery. In a laboratory animal setting, they can interact significantly with the aims of specific research protocols, and confound research results.
Other problems become apparent when parallels are made with pain assessment schemes that are used in man. The linearity of animal pain scoring schemes is often questionable. Even more difficult to assess is what degree of pain reduction is perceived as being beneficial by the individual animal. Addressing these issues requires both further development of assessment systems, and a major advance in our understanding of the nature of pain in animals.
| Animal pain, or animal nociception? |
|---|
|
|
|---|
For many years, there has been a debate about the nature of animal pain. The International Association for the Study of Pain (IASP) definition17 which highlights that pain is both a sensory and emotional experience, has in some circumstances led to the view that animal pain is a different experience from that in man. Animal pain was similar to the pain in lobotomized humans,22 or down-graded and considered solely as nociception. This controversy arises primarily because of the uncertainty as to whether animals have the conscious emotional states needed to experience pain in a similar manner to humans. Recent developments in animal cognition, and in imaging technology, are now beginning to address this difficult issue. On reflection, one major block to acceptance that animals have conscious emotional experiences relates to our equating consciousness with self-consciousness, or self-awareness. This difficulty can be overcome by accepting that consciousness developed gradually during evolution, and that different species will have different degrees or qualities of consciousness.1 7 Experiencing emotional states is not dependent on higher level consciousness (as found in man and possibly some animal species such as the great apes), but on more basic forms of consciousness. Possession of these forms of consciousness is thought necessary for certain types of ability and behaviours, and it is therefore possible to determine which species of animals possess these characteristics. It is also possible to demonstrate that nociceptive stimuli activate areas of the brain associated with the emotional component of pain in man.13 Recent new approaches to assessing the affective state of animals, for example by examining cognitive biases, offer the prospect of assessing the influence of noxious stimuli on emotional state in animals.10 25 Further work in these areas may lead to a major improvement in our understanding of emotional states in animals, and of the affective nature and quality of animal pain.
| Pain management in animals |
|---|
|
|
|---|
Although debates as to the nature of animal pain may eventually inform our attitudes and approaches to alleviating pain in veterinary practice, most veterinary anaesthetists simply assume animals experince pain and seek to manage it effectively. A wide range of clinical techniques have been developed, largely by extrapolation from clinical experience in man and based on the comparative aspects of the pathophysiology of pain in man and animals.35 In small animal and equine practice in the UK, systemic administration of non-steroidal anti-inflammatory drugs (NSAIDs) and opioids form the most frequently used means of managing postoperative pain. However, as mentioned earlier, routine use of analgesia is not yet uniform.8 16 26 As many veterinary patients are discharged within a short period of undergoing surgery, longer acting analgesics have become widely used, notably buprenorphine. The respiratory depressant effects of opioids used for postoperative analgesia in the mammals that are encountered in small animal practice seem significantly less than in humans. As a result, discharging an animal shortly after administering a long-acting opioid very rarely results in any clinically significant side-effects.
Preventive analgesia and multimodal approaches to pain management are extensively advocated by specialist veterinary anaesthetists, but it is difficult to determine how widespread or successful this approach is in general practice.12 Similarly, in specialist practice, particularly in veterinary schools and referral centres, other techniques such as the use of N-methyl-D-aspartate antagonists (e.g. ketamine),32 and a range of local anaesthetic techniques have all been advocated.6 Management of chronic pain is also developing—use of NSAIDs, including selective COX-2 inhibitors for the treatment of musculoskeletal pain is well established,20 and there are also recent reports of the identification and management of neuropathic pain.4
This increased enthusiasm for pain management has been reflected in the establishment of the International Academy of Veterinary Pain Management, the renaming of the journal Veterinary Anaesthesia to Veterinary Anaesthesia and Analgesia, reflecting its new content, and the establishment of a special interest group of the IASP focused on pain in non-human species.
| Animal pain and human pain—the relevance of comparative medicine |
|---|
|
|
|---|
Apart from providing an interesting insight into the challenges facing veterinary surgeons, the preceding review of veterinary pain management has potentially much greater significance. Current animal models designed to further our understanding of pain in man, and specifically to develop new treatment modalities have been recognized to have significant deficits.23 34 More clinically relevant information may be obtained by the study of naturally occuring models in animals. A more sophisticated understanding of an animal's response to pain, and in particular to the influence of pain on affective state, should allow the development of models that enable the emotional, and the sensory components of pain to be assessed. This may be of critical importance in the development of therapies for chronic and neuropathic pain. For many years, animal pain management has benefited from the use of analgesics used in man. In the future, a better understanding of animal pain might lead to translation of therapies in the opposite direction.
| References |
|---|
|
|
|---|
1 Arhem P, Liljenstrom H. On the coevolution of cognition and consciousness. J Theor Biol (1997) 187:601–12.[CrossRef][Web of Science][Medline]
2 Brearly JC, Brearley MJ. Chronic pain in animals. In: Pain Management in Animals—Flecknell P, Waterman-Pearson A, eds. (2000) London: W.B. Saunders.
3 Capner CA, Lascelles BDX, Waterman-Pearson AE. Current British veterinary attitudes to perioperative analgesia for dogs. Vet Rec (1999) 145:95–9.
4 Davis JL, Posner LP, Elce Y. Gabapentin for the treatment of neuropathic pain in a pregnant horse. J Am Vet Med Assoc (2007) 231:755–8.[CrossRef][Web of Science][Medline]
5 Dohoo SE, Dohoo IR. Factors influencing the postoperative use of analgesics in dogs and cats by Canadian veterinarians. Can Vet J (1996) 37:552–6.[Web of Science][Medline]
6 Driessen B. Pain: systemic and local/regional drug therapy. Clin Tech Equine Pract (2007) 6:135–44.[CrossRef]
7 Duncan IJH. Animal welfare defined in terms of feelings. Acta Agric Scand Sect A Animal Sci (1996) 27(Suppl.):29–35.
8 Fitzpatrick J, Scott M, Nolan A. Assessment of pain and welfare in sheep. Small Rum Res (2006) 62:55–61.[CrossRef]
9 Grisneaux E, Pibarot P, Dupuis J, Blais D. Comparison of ketoprofen and carprofen administered prior to orthopedic surgery for control of postoperative pain in dogs. J Am Vet Med Assoc (1999) 215:1105–10.[Web of Science][Medline]
10 Harding EJ, Paul ES, Mendl M. Cognitive bias and affective state. Nature (2004) 427:312.[CrossRef][Medline]
11 Hazewinkel HAW, van den Brom WE, Theyse LFH, Pollmeier M, Hanson PD. Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs. Res Vet Sci (2008) 84:74–9.[CrossRef][Medline]
12 Hellyer P, Rodan I, Brunt J, Downing R, Hagedorn JE, Robertson SA. AAHA/AAFP pain management guidelines for dogs and cats. J Feline Med Surg (2007) 9:466–80.[CrossRef][Web of Science][Medline]
13 Hess A, Sergejeva M, Budinsky L, Zeilhofer HU, Brune K. Imaging of hyperalgesia in rats by functional MRI. Eur J Pain (2007) 11:109–19.[Web of Science][Medline]
14 Hewson CJ, Dohoo IR, Lemke KA, Barkema HW. Canadian veterinarians' use of analgesics in cattle, pigs, and horses in 2004 and 2005. Can Vet J (2007) 48:155–64.[Web of Science][Medline]
15 Holton L, Reid J, Scott EM, Pawson P, Nolan A. The development of a behavioural based pain scale to measure acute pain in dogs. Vet Rec (2001) 148:525–31.
16 Huxley JN, Whay HR. Current attitudes of cattle practitioners to pain and the use of analgesics in cattle. Vet Rec (2006) 159:662–8.
17 International Association for the Study of Pain (IASP). Pain terms: a list with definitions and notes on usage. Pain (1979) 6:249–52.[Medline]
18 Lascelles BD, Cripps P, Mirchandani S, Waterman AE. Carprofen as an analgesic for postoperative pain in cats: dose titration and assessment of efficacy in comparison to pethidine hydrochloride. J Small Anim Pract (1995) 36:535–41.[CrossRef][Web of Science][Medline]
19 Lascelles BDX, Capner CA, Waterman-Pearson AE. Current British veterinary attitudes to perioperative analgesia for cats and small mammals. Vet Rec (1999) 145:601–4.
20 Lascelles BDX, Court MH, Hardie EM, Robertson SA. Nonsteroidal anti-inflammatory drugs in cats: a review. Vet Anaesth Anal (2007) 34:228–50.[CrossRef]
21 Lester SJ, Mellor DJ, Holmes RJ, Ward RN, Stafford KJ. Behavioural and cortisol responses of lambs to castration and tailing using different methods. NZ Vet J (1996) 44:45–54.
22 Melzack R, Dennis SG. Phylogenetic evolution of pain-expression in animals. In: Pain and Society—Kosterlitz HW, Terenius LY, eds. (1980) 13–26. Berlin: Verlag Chemie.
23 Mogil JS, Crager SE. What should we be measuring in behavioral studies of chronic pain in animals? Pain (2004) 112:12–5.[CrossRef][Web of Science][Medline]
24 Moloney V, Kent JE, McKendrick IJ. Validation of a method for assessment of an acute pain in lambs. Appl Anim Behav Sci (2002) 76:215–38.[CrossRef][Web of Science]
25 Paul ES, Harding EJ, Mendl M. Measuring emotional processes in animals: the utility of a cognitive approach. Neurosci Biobehav Rev (2005) 29:469–91.[CrossRef][Web of Science][Medline]
26 Price J, Eager RA, Welsh EM, Waran NK. Current practice relating to equine castration in the UK. Res Vet Sci (2005) 78:277–80.[CrossRef][Web of Science][Medline]
27 Raekallio M, Heinonem KM, Kuussaari J, Vainio O. Pain alleviation in animals. Attitudes and practices of Finnish veterinarians. Vet J (2003) 165:131–5.[CrossRef][Web of Science][Medline]
28 Richardson CA, Flecknell PA. Anaesthesia and post-operative analgesia following experimental surgery in laboratory rodents: are we making progress? Altern Lab Anim (2005) 33:119–27.[Medline]
29 Roughan JV, Flecknell PA. Effects of surgery and analgesic administration on spontaneous behaviour in singly housed rats. Res Vet Sci (2000) 69:283–8.[CrossRef][Web of Science][Medline]
30 Roughan JV, Flecknell PA. Behavioural effects of laparotomy and analgesic effects of ketoprofen and carprofen in rats. Pain (2001) 90:65–74.[CrossRef][Web of Science][Medline]
31 Slingsby LS, Waterman-Pearson AE. Comparison of pethidine, buprenorphine and ketoprofen for postoperative analgesia after ovariohysterectomy in the cat. Vet Rec (1998) 143:185–9.
32 Slingsby LS, Waterman-Pearson AE. The post-operative analgesic effects of ketamine after canine ovariohysterectomy—a comparison between pre- or post-operative administration. Res Vet Sci (2000) 69:147–52.[CrossRef][Web of Science][Medline]
33 Symonds KD, MacAllister CG, Erkert RS, Payton ME. Use of force plate analysis to assess the analgesic effects of etodolac in horses with navicular syndrome. Am J Vet Res (2006) 67:557–61.[CrossRef][Web of Science][Medline]
34 Vierck CJ, Hansson PT, Yezierski RP. Clinical and pre-clinical pain assessment: are we measuring the same thing? Pain (2008) 135:7–10.[CrossRef][Web of Science][Medline]
35 Vinuela-Fernandez I, Jones E, Welsh EM, Fleetwood-Walker SM. Pain mechanisms and their implication for the management of pain in farm and companion animals. Vet J (2007) 174:227–39.[CrossRef][Web of Science][Medline]
36 Wright-Williams SL, Courade J-P, Richardson CA, Roughan JV, Flecknell PA. Effects of vasectomy surgery and meloxicam treatment on faecal corticosterone and behaviour in two strains of laboratory mouse. Pain (2007) 130:108–18.[CrossRef][Web of Science][Medline]
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. A. Colvin and D. G. Lambert Pain medicine: advances in basic sciences and clinical practice Br. J. Anaesth., July 1, 2008; 101(1): 1 - 4. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
